Skip to content

Clinical trials

Phase 2 Osteoarthritis, Hip trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoarthritis, Hip Phase: Phase 2 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20072
20092
20112
20121
20161
20171
20181
20192
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated6
Unknown status3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pacira Pharmaceuticals, Inc3
Regeneron Pharmaceuticals2
Cara Therapeutics, Inc.1
Celltex Therapeutics Corporation1
CrystalGenomics, Inc.1
Hans Mallmin1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Northern Orthopaedic Division, Denmark1
Pfizer1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoarthritis, Hip19
Osteoarthritis, Knee8
Osteoarthritis7
Pain3
Arthralgia1
Arthritis1
Inflammation1
Joint Diseases1
Mobility Limitation1
Musculoskeletal Diseases1

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.